Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Biocon Limited
Press Release Jul 29 2021
Jul 29 2021
3 min read

Press Release Jul 29 2021

Biocon Limited has informed the Exchange regarding a press release dated July 29, 2021, titled "Biocon Biologics and Viatris Inc. Receive Historic Approval for First Interchangeable Biosimilar Semglee�� (insulin glargine-yfgn injection) for the Treatment of Diabetes.".

View Attachment